Resistance to Immunotherapeutic Antibodies in Cancer Strategies to Overcome Resistance /
The current application of antibody-meditated targeted therapy against cancer has resulted in significant objective clinical responses, prolongation of survival and even cures. More than 20 mAbs have been approved for human use targeting a range of different cancers. However, a major drawback of mAb...
| Corporate Author: | |
|---|---|
| Other Authors: | |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
New York, NY :
Springer New York : Imprint: Springer,
2013.
|
| Series: | Resistance to Targeted Anti-Cancer Therapeutics,
2 |
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
